tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Roivant Sciences price target raised to $30 from $28 at Guggenheim
PremiumThe FlyRoivant Sciences price target raised to $30 from $28 at Guggenheim
4d ago
Roivant Sciences price target raised to $26 from $22 at BofA
Premium
The Fly
Roivant Sciences price target raised to $26 from $22 at BofA
5d ago
Roivant Sciences price target raised to $38 from $28 at TD Cowen
Premium
The Fly
Roivant Sciences price target raised to $38 from $28 at TD Cowen
7d ago
Roivant Sciences announces upcoming milestones
PremiumThe FlyRoivant Sciences announces upcoming milestones
7d ago
Priovant reports Phase 2 results for brepocitinib in cutaneous sarcoidosis
Premium
The Fly
Priovant reports Phase 2 results for brepocitinib in cutaneous sarcoidosis
7d ago
ROIV Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ROIV Earnings this Week: How Will it Perform?
10d ago
Roivant Sciences: Promising Future with Strong Pipeline and Financial Stability
PremiumRatingsRoivant Sciences: Promising Future with Strong Pipeline and Financial Stability
2M ago
Roivant Sciences: Promising Outlook with Phase 3 Success and Robust Pipeline Drives Buy Rating
Premium
Ratings
Roivant Sciences: Promising Outlook with Phase 3 Success and Robust Pipeline Drives Buy Rating
2M ago
Roivant Sciences price target raised to $26 from $23 at H.C. Wainwright
Premium
The Fly
Roivant Sciences price target raised to $26 from $23 at H.C. Wainwright
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100